Comprehensive Analysis of the Butyrate-Metabolism-Related Gene Signature in Tumor Microenvironment-Infiltrating Immune Cells in Clear Cell Renal Cell Carcinoma

A wealth of experimental evidence has validated that butyrate is capable of inhibiting tumorigenesis, while the potential role of butyrate metabolism in the tumor immune microenvironment (TIME) has been rarely explored. This study aims to explore the potential of butyrate-metabolism-related genes as...

Full description

Bibliographic Details
Main Authors: Gang Tang, Haochen Guan, Zhiyong Du, Weijie Yuan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2022.816024/full
_version_ 1828348320169328640
author Gang Tang
Haochen Guan
Zhiyong Du
Weijie Yuan
author_facet Gang Tang
Haochen Guan
Zhiyong Du
Weijie Yuan
author_sort Gang Tang
collection DOAJ
description A wealth of experimental evidence has validated that butyrate is capable of inhibiting tumorigenesis, while the potential role of butyrate metabolism in the tumor immune microenvironment (TIME) has been rarely explored. This study aims to explore the potential of butyrate-metabolism-related genes as prognostic biomarkers and their correlations with immune infiltrates in clear cell renal cell carcinoma (ccRCC) patients. Based on The Cancer Genome Atlas dataset (TCGA; n = 539), a total of 22 differentially expressed genes (DEGs) related with butyrate metabolism in ccRCC and normal samples were identified. Among them, a prognostic signature involving six butyrate-metabolism-related genes was created (Bu-Meta-GPS) in the training set (n = 271) and validation set (n = 268), and risk scores were calculated based on them. ccRCC patients with high-risk scores exhibited an unfavorable prognosis, high immunoscore, upregulated immuno-oncological targets (PD1, PD-L1, CTLA4, and CD19), and distinct immune-cell infiltration than those with low-risk scores. High-risk ccRCC patients without radiotherapy had a better survival rate than radiotherapy-treated patients. The negative regulation of cytokine production and cytokine-mediated signaling pathways was remarkably enriched in ccRCC patients with high-risk scores. A nomogram was then formulated to assess the overall survival (OS) of ccRCC patients. In summary, we illuminated the key role of butyrate metabolism in ccRCC TIME. The developed Bu-Meta-GPS was a sensitive predictive biomarker for the prognosis of ccRCC, which also provided new perspectives in improving immunotherapeutic efficacy.
first_indexed 2024-04-14T00:53:11Z
format Article
id doaj.art-fb33c9740c754f02a84959f3b9a8c146
institution Directory Open Access Journal
issn 2296-634X
language English
last_indexed 2024-04-14T00:53:11Z
publishDate 2022-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj.art-fb33c9740c754f02a84959f3b9a8c1462022-12-22T02:21:44ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2022-05-011010.3389/fcell.2022.816024816024Comprehensive Analysis of the Butyrate-Metabolism-Related Gene Signature in Tumor Microenvironment-Infiltrating Immune Cells in Clear Cell Renal Cell CarcinomaGang Tang0Haochen Guan1Zhiyong Du2Weijie Yuan3Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Urology Surgery, Dingzhou People’s Hospital of Hebei Province, Dingzhou, ChinaDepartment of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaA wealth of experimental evidence has validated that butyrate is capable of inhibiting tumorigenesis, while the potential role of butyrate metabolism in the tumor immune microenvironment (TIME) has been rarely explored. This study aims to explore the potential of butyrate-metabolism-related genes as prognostic biomarkers and their correlations with immune infiltrates in clear cell renal cell carcinoma (ccRCC) patients. Based on The Cancer Genome Atlas dataset (TCGA; n = 539), a total of 22 differentially expressed genes (DEGs) related with butyrate metabolism in ccRCC and normal samples were identified. Among them, a prognostic signature involving six butyrate-metabolism-related genes was created (Bu-Meta-GPS) in the training set (n = 271) and validation set (n = 268), and risk scores were calculated based on them. ccRCC patients with high-risk scores exhibited an unfavorable prognosis, high immunoscore, upregulated immuno-oncological targets (PD1, PD-L1, CTLA4, and CD19), and distinct immune-cell infiltration than those with low-risk scores. High-risk ccRCC patients without radiotherapy had a better survival rate than radiotherapy-treated patients. The negative regulation of cytokine production and cytokine-mediated signaling pathways was remarkably enriched in ccRCC patients with high-risk scores. A nomogram was then formulated to assess the overall survival (OS) of ccRCC patients. In summary, we illuminated the key role of butyrate metabolism in ccRCC TIME. The developed Bu-Meta-GPS was a sensitive predictive biomarker for the prognosis of ccRCC, which also provided new perspectives in improving immunotherapeutic efficacy.https://www.frontiersin.org/articles/10.3389/fcell.2022.816024/fullbutyratemetabolismtumor immune microenvironmentccRCCgene signature
spellingShingle Gang Tang
Haochen Guan
Zhiyong Du
Weijie Yuan
Comprehensive Analysis of the Butyrate-Metabolism-Related Gene Signature in Tumor Microenvironment-Infiltrating Immune Cells in Clear Cell Renal Cell Carcinoma
Frontiers in Cell and Developmental Biology
butyrate
metabolism
tumor immune microenvironment
ccRCC
gene signature
title Comprehensive Analysis of the Butyrate-Metabolism-Related Gene Signature in Tumor Microenvironment-Infiltrating Immune Cells in Clear Cell Renal Cell Carcinoma
title_full Comprehensive Analysis of the Butyrate-Metabolism-Related Gene Signature in Tumor Microenvironment-Infiltrating Immune Cells in Clear Cell Renal Cell Carcinoma
title_fullStr Comprehensive Analysis of the Butyrate-Metabolism-Related Gene Signature in Tumor Microenvironment-Infiltrating Immune Cells in Clear Cell Renal Cell Carcinoma
title_full_unstemmed Comprehensive Analysis of the Butyrate-Metabolism-Related Gene Signature in Tumor Microenvironment-Infiltrating Immune Cells in Clear Cell Renal Cell Carcinoma
title_short Comprehensive Analysis of the Butyrate-Metabolism-Related Gene Signature in Tumor Microenvironment-Infiltrating Immune Cells in Clear Cell Renal Cell Carcinoma
title_sort comprehensive analysis of the butyrate metabolism related gene signature in tumor microenvironment infiltrating immune cells in clear cell renal cell carcinoma
topic butyrate
metabolism
tumor immune microenvironment
ccRCC
gene signature
url https://www.frontiersin.org/articles/10.3389/fcell.2022.816024/full
work_keys_str_mv AT gangtang comprehensiveanalysisofthebutyratemetabolismrelatedgenesignatureintumormicroenvironmentinfiltratingimmunecellsinclearcellrenalcellcarcinoma
AT haochenguan comprehensiveanalysisofthebutyratemetabolismrelatedgenesignatureintumormicroenvironmentinfiltratingimmunecellsinclearcellrenalcellcarcinoma
AT zhiyongdu comprehensiveanalysisofthebutyratemetabolismrelatedgenesignatureintumormicroenvironmentinfiltratingimmunecellsinclearcellrenalcellcarcinoma
AT weijieyuan comprehensiveanalysisofthebutyratemetabolismrelatedgenesignatureintumormicroenvironmentinfiltratingimmunecellsinclearcellrenalcellcarcinoma